AZD-0424

DB13088InvestigationalSmall molecule

AZD0424 has been used in trials studying the treatment of Advanced Solid Tumours.

Mechanism: Pharmacologically active on Tyrosine-protein kinase ABL1 and Proto-oncogene tyrosine-protein kinase Src
Curator reviewed
Formula / weight: C₂₅H₂₉ClN₆O₅ · 528.99 g/mol (avg)
Code names: AZD0424

Resolves to

Compound

Structure

InChIKeyMVWATCATLSSVBH-UHFFFAOYSA-NSMILESCC(C)OC1=C2C(NC3=C(Cl)C=NC4=C3OCO4)=NC=NC2=CC(OCCN2CCN(CC2)C(C)=O)=C1

Targets

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with AZD-0424, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.